Caribou Biosciences (CRBU) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CRBU Stock Alerts $3.71 -0.05 (-1.33%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Caribou Biosciences Short Interest DataCurrent Short Volume11,340,000 sharesPrevious Short Volume10,200,000 sharesChange Vs. Previous Month+11.18%Dollar Volume Sold Short$46.15 millionShort Interest Ratio / Days to Cover7.1Last Record DateApril 15, 2024Outstanding Shares90,320,000 sharesFloat Size79,620,000 sharesShort Percent of Float14.24%Today's Trading Volume1,044,519 sharesAverage Trading Volume1,618,709 sharesToday's Volume Vs. Average65% Short Selling Caribou Biosciences ? Sign up to receive the latest short interest report for Caribou Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRBU Short Interest Over TimeCRBU Days to Cover Over TimeCRBU Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy Caribou Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,340,000 shares $46.15 million +11.2%14.2%7.1 $4.07 3/31/202410,200,000 shares $52.43 million +1.3%12.9%6.2 $5.14 3/15/202410,070,000 shares $54.08 million +7.2%12.7%6.1 $5.37 2/29/20249,390,000 shares $74.27 million -3.1%12.1%6.1 $7.91 2/15/20249,690,000 shares $67.83 million -4.3%12.5%6.2 $7.00 1/31/202410,120,000 shares $62.04 million +2.6%13.6%6.1 $6.13 Get the Latest News and Ratings for CRBU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Caribou Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20249,860,000 shares $53.64 million +2.3%13.2%5.6 $5.44 12/31/20239,640,000 shares $55.24 million -3.0%12.9%5.9 $5.73 12/15/20239,940,000 shares $60.53 million +0.5%13.7%6.5 $6.09 11/30/20239,890,000 shares $58.05 million +10.5%13.7%6 $5.87 11/15/20238,950,000 shares $41.80 million -8.5%12.4%5.3 $4.67 10/31/20239,780,000 shares $35.50 million +24.4%12.9%6 $3.63 10/15/20237,860,000 shares $32.93 million -28.9%10.4%5.3 $4.19 9/30/202311,050,000 shares $52.82 million +34.6%14.6%5.7 $4.78 9/15/20238,210,000 shares $48.11 million +20.9%10.8%2.4 $5.86 8/31/20236,790,000 shares $39.99 million -0.7%9.1%2.1 $5.89 8/15/20236,840,000 shares $45.01 million -6.2%9.2%2.2 $6.58 7/31/20237,290,000 shares $52.42 million -11.1%11.4%2.4 $7.19 7/15/20238,200,000 shares $51.66 million +31.8%12.8%2.9 $6.30 6/30/20236,220,000 shares $26.44 million -17.9%11.6%2.6 $4.25 6/15/20237,580,000 shares $34.87 million -4.3%14.2%10.1 $4.60 5/31/20237,920,000 shares $34.93 million +5.6%14.8%13.1 $4.41 5/15/20237,500,000 shares $33.75 million +9.2%14.0%13.9 $4.50 4/30/20236,870,000 shares $29.54 million +22.0%12.8%13.8 $4.30 4/15/20235,630,000 shares $25.79 million +7.9%10.5%11.1 $4.58 3/31/20235,220,000 shares $27.72 million +10.8%9.8%10.9 $5.31 3/15/20234,710,000 shares $24.30 million +10.1%8.8%9.2 $5.16 2/28/20234,280,000 shares $26.07 million -5.5%8.0%8.2 $6.09 2/15/20234,530,000 shares $30.62 million +3.7%8.5%8.4 $6.76 1/31/20234,370,000 shares $31.51 million No Change8.6%8 $7.21 1/15/20234,370,000 shares $31.55 million +14.7%8.6%7.6 $7.22 12/30/20223,810,000 shares $23.93 million +10.4%7.5%6.6 $6.28 12/15/20223,450,000 shares $26.67 million +3.3%6.8%6.1 $7.73 11/30/20223,340,000 shares $31.10 million +1.8%6.6%5.1 $9.31 11/15/20223,280,000 shares $33.13 million -9.4%6.5%4.9 $10.10 10/31/20223,620,000 shares $35.26 million -8.8%7.2%4.8 $9.74 10/15/20223,970,000 shares $37.12 million -1.5%7.8%5.2 $9.35 9/30/20224,030,000 shares $42.52 million +39.9%8.0%5.5 $10.55 9/15/20222,880,000 shares $36.84 million +15.2%5.7%3.9 $12.79 8/31/20222,500,000 shares $24.68 million -14.4%4.9%3.3 $9.87Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. CRBU Short Interest - Frequently Asked Questions What is Caribou Biosciences' current short interest? Short interest is the volume of Caribou Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 11,340,000 shares of CRBU short. 14.24% of Caribou Biosciences' shares are currently sold short. Learn More on Caribou Biosciences' current short interest. What is a good short interest ratio for Caribou Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRBU shares currently have a short interest ratio of 7.0. Learn More on Caribou Biosciences's short interest ratio. Which institutional investors are shorting Caribou Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Caribou Biosciences: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Caribou Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.24% of Caribou Biosciences' floating shares are currently sold short. Is Caribou Biosciences' short interest increasing or decreasing? Caribou Biosciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 11,340,000 shares, an increase of 11.2% from the previous total of 10,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Caribou Biosciences' float size? Caribou Biosciences currently has issued a total of 90,320,000 shares. Some of Caribou Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Caribou Biosciences currently has a public float of 79,620,000 shares. How does Caribou Biosciences' short interest compare to its competitors? 14.24% of Caribou Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Caribou Biosciences: Aura Biosciences, Inc. (6.50%), Tenaya Therapeutics, Inc. (5.41%), TScan Therapeutics, Inc. (1.09%), Solid Biosciences Inc. (3.47%), Adaptive Biotechnologies Co. (7.23%), Jasper Therapeutics, Inc. (4.18%), Tourmaline Bio, Inc. (11.58%), SOPHiA GENETICS SA (0.10%), iTeos Therapeutics, Inc. (7.43%), Replimune Group, Inc. (18.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Caribou Biosciences stock? Short selling CRBU is an investing strategy that aims to generate trading profit from Caribou Biosciences as its price is falling. CRBU shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Caribou Biosciences? A short squeeze for Caribou Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBU, which in turn drives the price of the stock up even further. How often is Caribou Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBU, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Aura Biosciences Short Interest Data Tenaya Therapeutics Short Interest Data TScan Therapeutics Short Interest Data Solid Biosciences Short Interest Data Adaptive Biotechnologies Short Interest Data Jasper Therapeutics Short Interest Data Tourmaline Bio Short Interest Data SOPHiA GENETICS Short Interest Data iTeos Therapeutics Short Interest Data Replimune Group Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRBU) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace